Callio Therapeutics
Leadership & Board
Key Executives
CEO & Co-FounderPiers Ingram
CSO & Co-FounderJerome Boyd-Kirkup
CMONaomi Hunder
CBOAngele Maki
Current Number of Employees17
Current LinkedIn Followers3,792
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$187M
Total Amount Raised$187M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$187M
Latest Funding Amount$187M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Company Momentum Positive
Articles Published on TipRanks6
Articles Published on TipRanks
6
LinkedIn Trend+3.32% followers
LinkedIn Trend
+3.32% followers
Workforce Trend+0.0% employees
Workforce Trend
+0.0% employees
Callio Therapeutics LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Company Momentum indicates whether the company is gaining or losing traction over time. This proprietary TipRanks metric analyzes changes in a company’s workforce and LinkedIn follower trends, balancing these signals together to generate an overall momentum sentiment.
Employee Trend
Callio Therapeutics had 17 employees as of April 27, 2026. The number of employees increased by 0 (0.00%) week-over-week.
17Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Callio Therapeutics had 3,792 followers as of April 27, 2026. The number of followers increased by 122 (3.32%) week-over-week.
3,792Latest Followers Count
122(3.32%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Mar 03, 2025
Series A
$187.00M
―
Investors
Series A
Series A
Series A
Series A
Series A
Series A
Series A
Series A
